Sedation in the intensive care unit
- 1 March 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 28 (3) , 854-866
- https://doi.org/10.1097/00003246-200003000-00041
Abstract
To describe the goals of sedative use in the intensive care unit and review the pharmacology of commonly used sedative drugs as well as to review pertinent publications in the literature concerning the comparative pharmacology of these drugs, with emphasis on outcomes related to sedation and comparative pharmacoeconomics. Publications in the scientific literature. Computer search of the literature with selection of representative articles. Proper choice and use of sedative drugs is based on knowledge of the pharmacology of commonly used agents and is an essential component of caring for patients in the intensive care unit. The large variability in pharmacokinetics and pharmacodynamics in the critically ill make it difficult to directly compare agents. Midazolam provides rapid and reliable amnesia, even when administered for low levels of sedation. Propofol may be useful when deeper levels of sedation and more rapid awakening are required. Lorazepam can be used for long-term sedation in more stable patients if rapidity of effect is not required. Further investigation in assessment of depth of sedation in the critically ill is needed. Continued study of costs, side effects, and appropriate dosing strategies of all sedative agents is needed to answer questions not sufficiently addressed in the current literature. An individualized approach to sedation based on knowledge of drug pharmacology is needed because of confounding variables including concurrent patient illness, depth of sedation, and concomitant use of analgesic agents.Keywords
This publication has 54 references indexed in Scilit:
- Pharmacokinetics and Pharmacodynamics of Sedatives and Analgesics in the Treatment of Agitated Critically Ill PatientsClinical Pharmacokinetics, 1997
- Benzodiazepines in Cardiovascular SurgerySeminars in Cardiothoracic and Vascular Anesthesia, 1997
- Polyethylene Glycol Nephrotoxicity Secondary to Prolonged High-Dose Intravenous LorazepamAnnals of Pharmacotherapy, 1995
- Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unitCritical Care Medicine, 1995
- Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α-hydroxymidazolam in healthy volunteersClinical Pharmacology & Therapeutics, 1992
- The Use of Sedative Agents in Critically Ill PatientsDrugs, 1992
- UNCONSCIOUSNESS ASSOCIATED WITH MIDAZOLAM AND ERYTHROMYCINBritish Journal of Anaesthesia, 1990
- MidazolamAnesthesiology, 1985
- Alterations in metabolism following injury: part IInjury, 1980
- Psychological and psychiatric aspects of painAnaesthesia, 1978